Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Reaching for a diet soda or artificially sweetened snack to lose weight or to enjoy a few more treats? A growing number of scientists believe that’s not a good idea.

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove safe and effective for chronic pain.

UAE -- The U.S. Food and Drug Administration (FDA) approved lately Tirzepatide ... to-severe obstructive sleep apnea and obesity. It is also approved in combination with a reduced-calorie diet and ...

while Hikma has already rolled out its own copycat following an FDA approval that came through shortly after Christmas. Complicating the issue for Novo, generic drug makers and compounders ...

Known as an aptamer drug ... The FDA grants orphan status to medicines and biologics for rare diseases that meet certain criteria, opening the way for incentives such as accelerated approval ...

The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for subcutaneous use for most previously approved adult, solid tumor Opdivo ...

Sequana Medical NV has announced the US FDA approval of its Alfapump system for treating recurrent or refractory ascites due to liver cirrhosis. This approval marks Alfapump as the first active ...

The Food and Drug Administration (FDA) gave the green light ... in combination with a reduced-calorie diet and increased physical activity. “Today’s approval marks the first drug treatment ...

After delay, Roche's Tecentriq Hybreza wins first FDA approval for a subcutaneous PD-L1 drug Opdivo Qvantig’s average administration time of less than five minutes was observed in the Checkmate ...

Hikma recently received the Food and Drug Administration’s permission ... older with Type 2 diabetes as an adjunct to diet and exercise. The FDA approved the first generic in this class of ...